These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 20400247

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The influence of premenopausal hormones on severity of climacteric symptoms and use of HRT.
    Fentiman IS, Allen D, Wheeler M, Rymer J.
    Climacteric; 2006 Apr; 9(2):135-45. PubMed ID: 16698660
    [Abstract] [Full Text] [Related]

  • 26. Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity.
    Alexander JL, Burger H, Dennerstein L, Woods NF, Davis SR, Kotz K, Van Winkle J, Richardson G, Ratka A, Kessel B.
    Expert Rev Neurother; 2007 Nov; 7(11 Suppl):S115-37. PubMed ID: 18039061
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
    Hedrick RE, Ackerman RT, Koltun WD, Halvorsen MB, Lambrecht LJ.
    Menopause; 2009 Nov; 16(1):132-40. PubMed ID: 18971794
    [Abstract] [Full Text] [Related]

  • 29. Vasomotor symptoms in aging Chinese women: findings from a prospective cohort study.
    Li J, Luo M, Tang R, Sun X, Wang Y, Liu B, Cui J, Liu G, Lin S, Chen R.
    Climacteric; 2020 Feb; 23(1):46-52. PubMed ID: 31269826
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease.
    Gast GC, Pop VJ, Samsioe GN, Grobbee DE, Nilsson PM, Keyzer JJ, Wijnands-van Gent CJ, van der Schouw YT.
    Menopause; 2011 Feb; 18(2):146-51. PubMed ID: 21127438
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Vasomotor symptoms and neurovegetative comorbidities on the menopause: insights from an Italian quantitative research.
    Graziottin A, Banerji V, Hall G.
    Gynecol Endocrinol; 2019 Sep; 35(9):762-766. PubMed ID: 31266379
    [Abstract] [Full Text] [Related]

  • 35. Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation.
    Thurston RC, El Khoudary SR, Sutton-Tyrrell K, Crandall CJ, Gold E, Sternfeld B, Selzer F, Matthews KA.
    Menopause; 2011 Oct; 18(10):1044-51. PubMed ID: 21926929
    [Abstract] [Full Text] [Related]

  • 36. Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center.
    Seritan AL, Iosif AM, Park JH, DeatherageHand D, Sweet RL, Gold EB.
    Menopause; 2010 Mar; 17(2):410-5. PubMed ID: 20216277
    [Abstract] [Full Text] [Related]

  • 37. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
    Mesch VR, Siseles NO, Maidana PN, Boero LE, Sayegh F, Prada M, Royer M, Schreier L, Benencia HJ, Berg GA.
    Climacteric; 2008 Mar; 11(6):509-17. PubMed ID: 18991078
    [Abstract] [Full Text] [Related]

  • 38. Is an unfavourable cardiovascular risk profile a risk factor for vasomotor menopausal symptoms? Results of a population-based cohort study.
    van den Berg MJ, Herber-Gast GC, van der Schouw YT.
    BJOG; 2015 Aug; 122(9):1252-8. PubMed ID: 25515605
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.